EUCOMPANYCHECK
GB · Companies House · Ownership structure
GENOMICS LIMITED
Company number 08839972 · Private Limited Company · Active. Its ownership runs 1 layer up, from its confirmation statements at Companies House.
Check company info, directors and shareholders from 20+ European countries at EUCompanyCheck
Ownership chart
GENOMICS LIMITED's ownership structure
Owners above, the companies it holds below, from confirmation statements filed at Companies House.
Company report
See every shareholder and holding
The free view masks some of the names and stakes in GENOMICS LIMITED's structure. The company report shows every shareholder and holding with stakes, layer by layer, the directors and their other companies, accounts, charges and insolvency history, and multiple layers of shareholders and directors found in 23 European countries. Ready in 24 hours, or 2 days for the global check, sent to your email.
Free company check: register details, directors and latest filings
Register details
Company facts
- Company number
- 08839972
- Status
- Active
- Company type
- Private Limited Company
- Incorporated
- 10 January 2014
- Registered office
- Oxford
- Country of origin
- United Kingdom
- Business
- Research and experimental development on biotechnology
- Latest accounts type
- Group
- Shareholder layers
- 1
Company details from the Companies House register of 1 September 2026.
At a glance
GENOMICS LIMITED's ownership
- Its latest confirmation statement with a shareholder list (27 October 2025) lists 61 shareholders: 5 companies and 56 other shareholders, such as people.
From confirmation statements filed at Companies House up to 19 June 2026. Shareholdings can change at any time: check the current position live before relying on it.
Shareholders · 1 layer
Who owns GENOMICS LIMITED
GENOMICS LIMITED's shareholders as listed in its latest confirmation statement, then the shareholders of each shareholder that is a UK company, layer by layer.
Every shareholder, layer by layer (61)
Layer 1
Shareholders of GENOMICS LIMITED · statement of 27 October 2025
| Shareholder | Stake | Shares | Class |
|---|---|---|---|
| CSC EMPLOYEE BENEFIT TRUSTEE (JERSEY) LIMITED | 10.27% | 1,943,554 | G ORDINARY |
| LANSDOWNE DEVELOPED MARKETS MASTER FUND LIMITED | 7.8% | 1,476,769 | SERIES A / SERIES B1 / SERIES B3 / SERIES C |
| IP2IPO PORTFOLIO (GP) LIMITED Company 10360684 | 7.69% | 1,455,177 | ORDINARY / SERIES A / SERIES B1 / SERIES C |
| Masked · in the company report | — | — | — |
| OXFORD SCIENCE ENTERPRISES PLC Company 09093331 | 7.02% | 1,327,949 | SERIES B1 / SERIES B3 / SERIES C |
| VERTEX PHARMACEUTICALS INCORPORATED | 6.16% | 1,166,667 | ORDINARY |
| FORESITE CAPITAL FUND IV, L.P. | 6.11% | 1,156,975 | SERIES B2 / SERIES B3 / SERIES C |
| SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC Company 09405653 | 4.94% | 934,444 | ORDINARY |
| MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY | 4.85% | 917,171 | SERIES C |
| IP2IPO AUSTRALIA HP PTY LTD | 4.2% | 794,881 | SERIES C |
| FORESITE CAPITAL FUND V, L.P. | 3.91% | 739,502 | SERIES B3 / SERIES C |
| SALICA SPECIAL OPPORTUNITIES FUND I SPV LIMITED | 3.82% | 723,333 | ORDINARY |
| INFINITY FUNDS S.C.A. SICAV-RAIF – GLOBAL OPPORTUNITIES FUND | 3.23% | 611,447 | SERIES C |
| F-PRIME CAPITAL PARTNERS HEALTH IT AND SERVICES FUND LP | 2.51% | 474,119 | SERIES B2 / SERIES B3 / SERIES C |
| IP VENTURE FUND II (GP) LLP Company OC384792 | 2.34% | 442,398 | ORDINARY / SERIES A / SERIES B1 / SERIES C |
| REBECCA LOUISE NORWOOD | 2.33% | 441,000 | ORDINARY |
| CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD | 2.21% | 417,956 | ORDINARY / SERIES C |
| PETER JAMES DONNELLY | 1.94% | 367,500 | ORDINARY |
| CHRIS SPENCER | 1.79% | 338,867 | ORDINARY |
| GILEAN MCVEAN | 1.63% | 308,700 | ORDINARY |
| JOHN EDWARD BALFOUR COLENUTT | 1.42% | 267,834 | ORDINARY |
| GERARD ANTON LUNTER | 1.32% | 249,900 | ORDINARY |
| CSC EMPLOYEE BENEFIT SERVICES (JERSEY) LIMITED | 1.06% | 201,345 | G ORDINARY |
| INFINITY FUNDS ICAV – LIFE SCIENCES FUND | 0.81% | 152,862 | SERIES C |
| TAMORER PTY LIMITED | 0.8% | 152,187 | ORDINARY |
Show all 61 shareholders
| Shareholder | Stake | Shares | Class |
|---|---|---|---|
| MDFSSSSF CO PTY LTD | 0.78% | 147,000 | ORDINARY |
| LANSDOWNE DEVELOPED MARKETS STRATEGIC INVESTMENT | 0.61% | 115,333 | SERIES A / SERIES B1 / SERIES B3 |
| MASTER FUND LIMITED | 0.61% | 115,333 | SERIES A / SERIES B1 / SERIES B3 |
| MICHAEL SIMPSON | 0.21% | 40,392 | ORDINARY |
| ALEX MICHAELIS BUELAU | 0.14% | 26,642 | ORDINARY |
| ALEXANDER LACHAPELLE | 0.11% | 20,833 | ORDINARY |
| YORK AVENUE PTY LTD | 0.11% | 20,000 | SERIES C |
| WILLIAM THOMAS O'CONNOR | 0.06% | 11,709 | SERIES C |
| SIMON DINGEMANS | 0.06% | 11,111 | ORDINARY |
| BARBARA ENGELHARDT | 0.04% | 8,222 | ORDINARY |
| IVAN GRIFFIN | 0.04% | 7,350 | ORDINARY |
| JONATHAN GRIFFITHS | 0.02% | 4,457 | ORDINARY |
| MARK ROBERT WARNE | 0.02% | 3,724 | ORDINARY |
| FELICITY ALLEN | 0.02% | 3,300 | ORDINARY |
| STUART TEASDALE | 0.01% | 2,750 | ORDINARY |
| OLI BATSTONE | 0.01% | 2,382 | ORDINARY |
| REKA NAGY | 0.01% | 1,869 | ORDINARY |
| ROBERT HOWLETT | 0.01% | 1,732 | ORDINARY |
| ANDREAS HEGER | 0.01% | 1,552 | ORDINARY |
| AMY GLEES | 0.01% | 1,330 | ORDINARY |
| CHRISTOPHER FRANKLIN | 0.01% | 1,243 | ORDINARY |
| EDWARD JOHN MOUNTJOY | 0.01% | 1,208 | ORDINARY |
| ALEXANDRA FISH | 0.01% | 1,000 | ORDINARY |
| MARIA SUCIU | 0.01% | 1,000 | ORDINARY |
| PRIYANKA SETH | 0.01% | 1,000 | ORDINARY |
| ROBERT MICHAEL SIVLEY | 0.01% | 1,000 | ORDINARY |
| ANDREW THOMASON | under 0.01% | 542 | ORDINARY |
| VIKTORIIA VARNAVAS | under 0.01% | 533 | ORDINARY |
| WAQAR ALI | under 0.01% | 500 | ORDINARY |
| CLARE BYCROFT | under 0.01% | 409 | ORDINARY |
| IP2IPO NOMINEES LIMITED Company 05602177 | under 0.01% | 333 | SERIES B1 |
| MICHAELA SPITZER | under 0.01% | 330 | ORDINARY |
| LARA WAINWRIGHT | under 0.01% | 300 | ORDINARY |
| OLIVER BOSLEY | under 0.01% | 10 | ORDINARY |
| ROBERT AMOS | under 0.01% | 1 | ORDINARY |
| ZHEYI ZHAO | under 0.01% | 1 | ORDINARY |
People with significant control
Who controls GENOMICS LIMITED
Companies House listed no people with significant control for GENOMICS LIMITED on 12 November 2026.
Officers · 10 current
Who runs GENOMICS LIMITED
GENOMICS LIMITED's directors and secretaries as registered at Companies House on 12 November 2026: 10 current and 11 former.
Current officers (10)
| Name | Role | Appointed | Nationality | Country of residence |
|---|---|---|---|---|
| PINSENT MASONS SECRETARIAL LIMITED | Corporate secretary | 1 October 2014 | — | — |
| DAVIES, Sally Claire, Professor | Director | 6 March 2020 | British | United Kingdom |
| DINGEMANS, Simon | Director | 7 September 2022 | British | United Kingdom |
| DONNELLY, Peter James, Professor | Director | 6 March 2014 | British,Australian | United Kingdom |
| GUTIERREZ-RAMOS, Jose-Carlos | Director | 6 November 2024 | American | United States |
| HERRERA, Kristin | Director | 25 June 2025 | American | United States |
| MCVEAN, Gilean Alistair Tristram, Professor | Director | 6 March 2014 | British | England |
| PASTEUR, Alexander Thomas | Director | 13 June 2024 | British | United Kingdom |
| SMITH, Gregory Simon | Director | 6 May 2026 | British | United Kingdom |
| TANANBAUM, James | Director | 6 December 2018 | American | United States |
Former officers (11)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| IP2IPO SERVICES LIMITED | Corporate secretary | 10 January 2014 | 1 October 2014 |
| ALTSHULER, David, Dr | Director | 28 August 2018 | 7 January 2024 |
| BARRETT, Jeffrey | Director | 21 March 2018 | 11 May 2020 |
| COLENUTT, John Edward Balfour | Director | 1 August 2014 | 31 December 2019 |
| KNIGHT, Stephen | Director | 6 December 2018 | 12 June 2024 |
| NORWOOD, David Robert | Director | 6 March 2014 | 13 June 2024 |
| WARNE, Mark Robert | Director | 21 November 2014 | 26 October 2018 |
| WARNE, Mark Robert | Director | 10 January 2014 | 6 March 2014 |
| WESTON, Charles | Director | 10 August 2015 | 24 March 2017 |
| WILLIAMS, Samuel Cameron | Director | 31 October 2018 | 7 May 2026 |
| IP2IPO SERVICES LIMITED | Corporate director | 6 March 2014 | 21 November 2014 |
Explained
How this chart is built
Every UK company files a confirmation statement with Companies House at least once a year, and private companies list their shareholders in it. The chart takes each company's latest statement with a shareholder list and follows every shareholder that is itself a UK company to that company's own statement, layer by layer. Holdings work the other way: every company whose latest statement lists the company as a shareholder, then the companies those hold.
A stake is the share of the company's issued shares, weighted by nominal value where the statement gives it. Each statement shows the position on its own date. Shareholders are matched to UK companies by their registered names, so a holder can occasionally be matched to the wrong company or not matched at all.
Live lookup
Check it live
With EUCompanyCheck connected, your AI assistant reads the current records straight from Companies House at the moment you ask. Try asking:
- Who are the current shareholders of GENOMICS LIMITED?
- Who has significant control of GENOMICS LIMITED today?
- Show me GENOMICS LIMITED's latest confirmation statement from Companies House.
- Who are the directors of GENOMICS LIMITED, and when were they appointed?
Get started
Company ownership, straight from the register
Connect Claude, ChatGPT or your editor and go deep into who owns and runs any company in 23 countries.